NEUROONE MEDICAL TECHNOLOGIES Corp·4

Apr 21, 4:44 PM ET

McClurg Ronald W. 4

4 · NEUROONE MEDICAL TECHNOLOGIES Corp · Filed Apr 21, 2025

Insider Transaction Report

Form 4
Period: 2025-04-17
McClurg Ronald W.
Chief Financial Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2025-04-17+250,000250,000 total
    Exercise: $0.58Exp: 2035-04-16Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]25% will vest on April 17, 2026, and the remaining 75% will vest in 12 equal quarterly installments.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT